1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US Blood Bank Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US Blood Bank Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Demand for Blood and Blood Products
- 5.1.2 Increasing Healthcare Expenditure
- 5.1.3 Modernization in Blood Storage and Transport Technology
5.2 Market Opportunities
- 5.2.1 Expansion of Blood Donation Initiatives in Emerging Markets
- 5.2.2 Government Initiatives and Public-Private Partnerships
- 5.2.3 Collaboration with Biotech and Pharmaceutical Companies
5.3 Future Trends
- 5.3.1 Integration of AI and Automation in Blood Bank Operations
- 5.3.2 Rise of Blood Plasma Collection
- 5.3.3 Shift Toward Blood Substitutes and Plasma-Based Therapies
5.4 Impact of Drivers and Restraints
6. US Blood Bank Market Regional Analysis
6.1 US Blood Bank Market Overview
6.2 US Blood Bank Market Revenue 2017-2027 (US$ Million)
6.3 US Blood Bank Market Forecast Analysis
7. US Blood Bank Market Analysis – by Type
7.1 Whole Blood
- 7.1.1 Overview
- 7.1.2 Whole Blood: US Blood Bank Market – Revenue and Forecast to 2031 (US$ Million)
7.2 RBC
- 7.2.1 Overview
- 7.2.2 RBC: US Blood Bank Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Platelets
- 7.3.1 Overview
- 7.3.2 Platelets: US Blood Bank Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Plasma
- 7.4.1 Overview
- 7.4.2 Plasma: US Blood Bank Market – Revenue and Forecast to 2031 (US$ Million)
7.5 WBC
- 7.5.1 Overview
- 7.5.2 WBC: US Blood Bank Market – Revenue and Forecast to 2031 (US$ Million)
8. US Blood Bank Market Analysis – by Function
8.1 Collection
- 8.1.1 Overview
- 8.1.2 Collection: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Processing
- 8.2.1 Overview
- 8.2.2 Processing: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Testing
- 8.3.1 Overview
- 8.3.2 Testing: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Storage
- 8.4.1 Overview
- 8.4.2 Storage: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Transportation
- 8.5.1 Overview
- 8.5.2 Transportation: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
9. US Blood Bank Market Analysis – by Bank Type
9.1 Private and Public
- 9.1.1 Overview
- 9.1.2 Transportation: US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
10. US Blood Bank Market – United States Analysis
10.1 United States
- 10.1.1 US Blood Bank Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 US Blood Bank Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 United States :
US Blood Bank Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 United States : US Blood Bank Market Breakdown, by Type
- 10.1.1.1.2 United States : US Blood Bank Market Breakdown, by Function
- 10.1.1.1.3 United States : US Blood Bank Market Breakdown, by Bank Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. US Blood Bank Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Bloodworks Northwest
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 San Diego Blood Bank
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 America’s Blood Centers
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CSL Plasma
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Blood Centers of America
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 The American National Red Cross
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New York Blood Center
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Vitalant
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Interstate Blood Bank, Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights